Institute for Toxicology and Experimental Medicine, the Universities of Dresden and Aarhus (Denmark), Gene Center in München, the Institute of Protein Research (Russian Academy of Science), the synchrotron
UKE Hamburg (Laufzeit: 1.07.2010 – 31.06.2011) DFG (KFG 123) Teilprojekt 3: Kompartiment-bezogene Gen- und Proteinexpression im Frühstadium der Bronchiolitis obliterans nach Lungentransplantation D. Steinemann [...] Schambach, Michael Ott, Hans R. Schöler, Tobias Cantz für die Arbeit: Generation of Healthy Mice from Gene-Corrected Disease-Specific Induced Pluripotent Stem Cells, erschienen in PLoS Biol 9(7), 2011 2015
Institute of Experimental Hematology Project: Stem and progenitor cells for disease modeling and gene therapy of hearing loss Final exam November 2024 Christian Melcher GERMANY Melcher.Christian @ mh-hannover [...] Axel Schambach, Insitute of Experimental Haematology, Project: Development and validation of novel gene therapeutic approaches for correction of and protection from hearing loss Final exam June 2024 Dimyana
Ferreira de Figueiredo (Transfusion Medicine) Project: Correction of monogenetic kidney diseases using a gene therapeutic approach Aavani Biju Sindhu INDIA; Sindhu.Aavani @ mh-hannover.de Supervisor: Prof. Dr [...] Felix @ mh-hannover.de Supervisor: Prof. Dr. Axel Schambach (Experimental Hematology) Project: Novel gene therapy strategies for inherited inner ear defects Lena Willmer GERMANY; lena.willmer @ item.fraunhofer
Robert @ mh-hannover.de Supervisor: Prof. Dr. Axel Schambach (Experimental Hematology) Project: Novel gene and immunotherapeutic approaches for the treatment of cervical cancer Pegah Rahmati IRAN Rahmati.Pegah [...] Pegah @ mh-hannover.de Supervisor: Prof. Dr. Britte Eiz-Vesper (Transfusion Medicine) Project: Gene-regulated EBV-specific T cells for personalized adoptive immunotherapy Final exam November 2024 Sonia
Down-regulation of the fetal stem cell factor SOX17 by H33342: a mechanism responsible for differential gene expression in breast cancer side population cells. J Biol Chem 2010; 285(9): 6412-8 Claus RA, Bockmeyer [...] rger B, Göhring G: Telomere shortening and chromosomal instability in myelodysplastic syndromes. Genes Chromosomes Cancer 2010; 49(3): 260-9 Lehmann U : [DNA methylation. From basic research to routine [...] Schlegelberger B, Länger F , Kreipe H , Lehmann U : Epigenetic inactivation of tumour suppressor gene KLF11 in myelodysplastic syndromes. Eur J Haematol 2010; 84(4): 298-303 Reich A, Maj J, Schlue J,
sowie vom Deutschen Zentrum für Infektionsforschung (DZIF) unterstützt. Das KSHV K15 Protein Das K15 Gen des Virus kodiert ein nicht-strukturelles Membranprotein, welches gewisse Ähnlichkeiten zu den latenten [...] sarcoma-associated herpesvirus vIRF2 protein utilizes an IFN-dependent pathway to regulate viral early gene expression. PLoS Pathogens 2019; 15(5):e1007743 Abere B, Samarina N, Gramolelli S, Rückert J, Gerold [...] inhibitory protein, vFLIP, from the viral genome compromises the activation of STAT1-responsive cellular genes and spindle cell formation in endothelial cells. J. Virol. 2011; 85:10375-88. Pietrek M, Brinkmann
transplantation enables the opportunity of pre-Tx modification of hepatocytes by technologies such as gene therapy. Unfortunately, the promising results obtained in animal models could not be successfully
g Promotion 2010 „Einfluss von Stickstoffmonoxid auf Freisetzung und Genexpression von Calcitonin gene-related peptide im trigeminalen Ganglion der Ratte“ Praktische Tätigkeiten und Qualifikationen bis
n (je teilnehmender GKV) Single-/Trio- Untersuchungsauftrag inklusive Einwilligungserklärung nach GenDG Bitte beachten Sie die Übersicht zum Patientenpfad sowie die Hinweise zur Anmeldung zu den inter